How did IRIX's Q4 earnings compare to forecasts?

Iridex's Q4 earnings fell short of forecasts, with the company reporting a net loss of $8.34 million and total revenue of $12.7 million. Here's a detailed comparison: 1. **Net Income**: Iridex's Q4 net income was -$8.34 million. This compares to the estimated earnings per share (EPS) of -$0.05, which would translate to a net income of approximately -$0.59 million, assuming no significant changes in the company's financials. It's clear that Iridex missed on earnings significantly. 2. **Revenue**: The reported total revenue for Q4 was $12.7 million. This is slightly higher than the estimated revenue of $12.6 million to $12.7 million that Iridex announced preliminarily. However, when compared to the previous year, revenue dipped from $12.5 million. 3. **Revenue by Product**: The Cyclo G6® product family contributed $3.3 million to the revenue, marking an increase from the prior year. This is a positive indicator, suggesting that this product line is performing well despite the overall revenue decline. 4. **Profitability Metrics**: Iridex reported a positive adjusted EBITDA of $0.4 million, a significant improvement from a negative $2.0 million in the prior year. This indicates that the company's cost-reduction program and strategic investments are yielding positive results. In conclusion, while Iridex's Q4 revenue was in line with preliminary estimates and showed growth in specific product areas, the company's net income fell below forecasts, resulting in a net loss. However, the company's strategic initiatives are showing signs of improvement in profitability.